Access cutting-edge temporal lobe epilepsy treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access temporal lobe epilepsy specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related temporal lobe epilepsy treatment provided free
This is a multicenter, single arm, open label clinical trial that is designed to test the safety and preliminary efficacy of single administration inhibitory nerve cells called interneurons (NRTX-1001), into both temporal lobes of subjects with drug-resistant bilateral mesial temporal lobe epilepsy.
Sponsor: Neurona Therapeutics
Check if you qualify for this temporal lobe epilepsy clinical trial in Palo Alto, CA
If you're searching for temporal lobe epilepsy treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced temporal lobe epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.